Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for sealant, orthobiologic and surgical wound indications, announced today that its patent application U.S.S.N 12/102,157 will issue today and has been assigned U.S. Patent No.

See the original post:
Kuros Biosurgery granted U.S. patent for synthetic hydrogel technology

Scroll to Top